Company news

Senti Biosciences Holdings, Inc. news in 2024

Senti Biosciences Holdings, Inc.'s news releases, calls and decks from 2024, newest first.

View company

Senti Bio Announces First Patient Dosed in Clinical Trial of SN301A in Hepatocellular Carcinoma in Collaboration with Celest Therapeutics

December 15, 2024

Senti Biosciences, Inc. Announces Oversubscribed $37.6 Million Private Placement Equity Financing

December 1, 2024

Senti Bio Appoints Fran Schulz to Board of Directors

December 1, 2024

Senti Bio Announces Positive Initial Clinical Data in Phase 1 Clinical Trial of SENTI-202, a Logic Gated, Selective CD33/FLT3-Targeting CAR-NK Cell Therapy for the Treatment of Relapsed/Refractory Hematologic Malignancies Including AML

December 1, 2024

Senti Bio Announces Third Quarter 2024 Results and Recent Pipeline and Corporate Highlights

November 13, 2024

Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights

August 12, 2024

Senti Bio Announces Execution of Grant Award from California Institute for Regenerative Medicines (CIRM) for Clinical Development of SENTI-202

August 4, 2024

Senti Bio Announces Reverse Stock Split

July 15, 2024

Senti Bio Awarded California Institute for Regenerative Medicines (CIRM) Grant for Clinical Development of Logic Gated CAR-NK Cell Therapy

June 30, 2024

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

May 12, 2024

Senti Bio Announces First Quarter 2024 Results and Reviews Recent Corporate Highlights

May 8, 2024

Senti Bio Announces Publication of SENTI-202 Preclinical Data Demonstrating Potential of Logic-Gated CAR-NK Cell Therapy for the Treatment of Acute Myeloid Leukemia (AML)

April 29, 2024

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

March 20, 2024

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

January 4, 2024

Decks in 2024